Healthpeak raises adjusted FFO guidance for third time in 2026
DOC•Healthpeak raised its 2026 FFO as Adjusted guidance for the third time, citing operating performance and external growth at Janus Living. Janus Living's third-quarter same-store NOI grew 26%, and Healthpeak cited $1.7 billion in acquisitions and buybacks targeting a 9%-10% stabilized cash yield.
1. Guidance and growth
Healthpeak raised its 2026 FFO as Adjusted guidance for the third time, citing operating performance and external growth at Janus Living. Janus Living's third-quarter same-store NOI grew 26%, supported by occupancy gains and rate growth. Healthpeak said investments totaling $1.7 billion in acquisitions and buybacks target a 9%-10% stabilized cash yield, compared with a 6% initial cash yield. About $200 million of additional outpatient dispositions are expected to close by year-end.
